Skip to content

Best Way to Control Myopia in Kids with Intermittent Wandering Eyes: Glasses, or Contacts

Randomized Controlled Trial Comparing Myopia Control Efficacy of Microstructure Frame Glasses and Orthokeratology Lenses in Patients with Intermittent Exotropia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103675
Enrollment
Unknown
Registered
2025-06-03
Start date
2025-06-06
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Orthokeratology Lens Treatment Group?:Orthokeratology Lens Treatment
Conventional Frame Glasses Control Group:Conventional Frame Glasses Control
Microstructure Frame Glasses Treatment Group:Microstructure Frame Glasses Treatment

Sponsors

The Zhongshan Ophthalmic Center,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1.Patients with intermittent exotropia aged 8 to 15 years old, regardless of gender. 2.The degree of exotropia is <= - 35 prism diopters (PD). 3.The patients have myopia ranging from - 4.00 to - 1.00 diopters (D) in both eyes, astigmatism <= 1.50 D. 4.The patients are able to complete a one - year follow - up. 5.The patients can understand the purpose of the trial, voluntarily participate, and sign the informed consent form either by themselves or by their guardians.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from systemic diseases such as diabetes, Down syndrome, rheumatoid arthritis, mental illness, etc., and those who have had acute or chronic sinusitis within 2 years. 2.Patients with other types of strabismus, severe anisometropia, or other eye diseases, or those who have undergone ocular surgeries, such as corneal infections, dry eye syndrome, and corneal surgeries. 3.Patients who have participated in or are currently participating in other myopia control studies or therapies. 4.Patients whose best - corrected distant visual acuity in either eye is lower than 1.0. 5.Patients with abnormal intraocular pressure (the normal range of intraocular pressure is 10 - 21 mmHg). 6.Patients who cannot understand the limitations of the treatment method. 7.Patients who are overly sensitive or have excessive expectations. 8.Other conditions in which the investigator deems the patient unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Axial length;

Countries

China

Contacts

Public ContactXiao Yang

The Zhongshan Ophthalmic Center,Sun Yat-sen University

yangxiao@gzzoc.com+86 20 8733 0410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026